Year-on-Year Variation:
2025: 8.79%
2026: 8.08%
2027: 7.48%
2028: 6.97%
CAGR (2024-2028): 7.83%
Forecasted sales of antiarrhythmic medicine in South Korea are projected to rise steadily from $34.1 million in 2024 to $46.1 million in 2028, depicting a consistent year-on-year growth. A key trend to watch would be the impact of potential new players in the market, advancements in medical technology, and changes in healthcare policies. Additionally, it is crucial to observe demographic shifts, as an aging population could increase the demand for antiarrhythmic medicines.
